Human papillomavirus seroprevalence among young male and female drug users

Sabrina S. Plitt, Susan Sherman, Raphael P Viscidi, Steffanie A. Strathdee, Crystal M. Fuller, Taha E Taha

Research output: Contribution to journalArticle

Abstract

OBJECTIVES: To determine seroprevalence and correlates of exposure to HPV 16, 18, and 53 among 15- to 30-year-old drug users in Baltimore, MD. STUDY DESIGN: Young, newly initiated injection and noninjection drug users underwent a behavioral risk assessment and HPV serology testing. Sex-specific analyses were performed comparing seropositive and seronegative participants using χ, Mann-Whitney tests, and logistic regression. RESULTS: Participants (n = 553) were 43.0% female, 40.2% African American, and median age was 24 years. HPV seroprevalence among females and males, respectively, was: HPV-16, 38.2% and 7.0%; HPV-18, 42.4% and 7.3%; and HPV-53, 27.7% and 5.1%. Correlates of HPV seropositivity among females included being African American and anal sex, and among males, having had sex with another male. CONCLUSIONS: HPV seroprevalence was high among young drug users and significantly higher among females than males, supporting previous findings. Further research is required to fully understand HPV risk factors among men and the contribution of anal transmission in women.

Original languageEnglish (US)
Pages (from-to)676-680
Number of pages5
JournalSexually Transmitted Diseases
Volume34
Issue number9
DOIs
StatePublished - Sep 2007

Fingerprint

Seroepidemiologic Studies
Drug Users
Human papillomavirus 18
Human papillomavirus 16
African Americans
Baltimore
Serology
Sexual Behavior
Logistic Models
Injections
Research

ASJC Scopus subject areas

  • Dermatology
  • Public Health, Environmental and Occupational Health
  • Microbiology (medical)

Cite this

Human papillomavirus seroprevalence among young male and female drug users. / Plitt, Sabrina S.; Sherman, Susan; Viscidi, Raphael P; Strathdee, Steffanie A.; Fuller, Crystal M.; Taha, Taha E.

In: Sexually Transmitted Diseases, Vol. 34, No. 9, 09.2007, p. 676-680.

Research output: Contribution to journalArticle

Plitt, Sabrina S. ; Sherman, Susan ; Viscidi, Raphael P ; Strathdee, Steffanie A. ; Fuller, Crystal M. ; Taha, Taha E. / Human papillomavirus seroprevalence among young male and female drug users. In: Sexually Transmitted Diseases. 2007 ; Vol. 34, No. 9. pp. 676-680.
@article{fc6ec4d141ae4a45861ede4d2f546d66,
title = "Human papillomavirus seroprevalence among young male and female drug users",
abstract = "OBJECTIVES: To determine seroprevalence and correlates of exposure to HPV 16, 18, and 53 among 15- to 30-year-old drug users in Baltimore, MD. STUDY DESIGN: Young, newly initiated injection and noninjection drug users underwent a behavioral risk assessment and HPV serology testing. Sex-specific analyses were performed comparing seropositive and seronegative participants using χ, Mann-Whitney tests, and logistic regression. RESULTS: Participants (n = 553) were 43.0{\%} female, 40.2{\%} African American, and median age was 24 years. HPV seroprevalence among females and males, respectively, was: HPV-16, 38.2{\%} and 7.0{\%}; HPV-18, 42.4{\%} and 7.3{\%}; and HPV-53, 27.7{\%} and 5.1{\%}. Correlates of HPV seropositivity among females included being African American and anal sex, and among males, having had sex with another male. CONCLUSIONS: HPV seroprevalence was high among young drug users and significantly higher among females than males, supporting previous findings. Further research is required to fully understand HPV risk factors among men and the contribution of anal transmission in women.",
author = "Plitt, {Sabrina S.} and Susan Sherman and Viscidi, {Raphael P} and Strathdee, {Steffanie A.} and Fuller, {Crystal M.} and Taha, {Taha E}",
year = "2007",
month = "9",
doi = "10.1097/01.olq.0000258309.42765.ac",
language = "English (US)",
volume = "34",
pages = "676--680",
journal = "Sexually Transmitted Diseases",
issn = "0148-5717",
publisher = "Lippincott Williams and Wilkins",
number = "9",

}

TY - JOUR

T1 - Human papillomavirus seroprevalence among young male and female drug users

AU - Plitt, Sabrina S.

AU - Sherman, Susan

AU - Viscidi, Raphael P

AU - Strathdee, Steffanie A.

AU - Fuller, Crystal M.

AU - Taha, Taha E

PY - 2007/9

Y1 - 2007/9

N2 - OBJECTIVES: To determine seroprevalence and correlates of exposure to HPV 16, 18, and 53 among 15- to 30-year-old drug users in Baltimore, MD. STUDY DESIGN: Young, newly initiated injection and noninjection drug users underwent a behavioral risk assessment and HPV serology testing. Sex-specific analyses were performed comparing seropositive and seronegative participants using χ, Mann-Whitney tests, and logistic regression. RESULTS: Participants (n = 553) were 43.0% female, 40.2% African American, and median age was 24 years. HPV seroprevalence among females and males, respectively, was: HPV-16, 38.2% and 7.0%; HPV-18, 42.4% and 7.3%; and HPV-53, 27.7% and 5.1%. Correlates of HPV seropositivity among females included being African American and anal sex, and among males, having had sex with another male. CONCLUSIONS: HPV seroprevalence was high among young drug users and significantly higher among females than males, supporting previous findings. Further research is required to fully understand HPV risk factors among men and the contribution of anal transmission in women.

AB - OBJECTIVES: To determine seroprevalence and correlates of exposure to HPV 16, 18, and 53 among 15- to 30-year-old drug users in Baltimore, MD. STUDY DESIGN: Young, newly initiated injection and noninjection drug users underwent a behavioral risk assessment and HPV serology testing. Sex-specific analyses were performed comparing seropositive and seronegative participants using χ, Mann-Whitney tests, and logistic regression. RESULTS: Participants (n = 553) were 43.0% female, 40.2% African American, and median age was 24 years. HPV seroprevalence among females and males, respectively, was: HPV-16, 38.2% and 7.0%; HPV-18, 42.4% and 7.3%; and HPV-53, 27.7% and 5.1%. Correlates of HPV seropositivity among females included being African American and anal sex, and among males, having had sex with another male. CONCLUSIONS: HPV seroprevalence was high among young drug users and significantly higher among females than males, supporting previous findings. Further research is required to fully understand HPV risk factors among men and the contribution of anal transmission in women.

UR - http://www.scopus.com/inward/record.url?scp=34548160492&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548160492&partnerID=8YFLogxK

U2 - 10.1097/01.olq.0000258309.42765.ac

DO - 10.1097/01.olq.0000258309.42765.ac

M3 - Article

C2 - 17847165

AN - SCOPUS:34548160492

VL - 34

SP - 676

EP - 680

JO - Sexually Transmitted Diseases

JF - Sexually Transmitted Diseases

SN - 0148-5717

IS - 9

ER -